Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

FHS
May 29, 2024
10:49 am

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specializing in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.

Ex-Cedilla CEO Glucksmann explores ‘new frontier’ at Sensorium; R&D chief out at Merck women’s health spinoff Organon

Alexandra Glucksmann is always looking for “the next frontier” in medicine. After spending most of her career in genetic diseases, rare diseases and oncology, her

December 9, 2023

Truveta Unveils Largest Mother-Child EHR Dataset for Pregnancy and Pediatric Research

What You Should Know: – Truveta, a data company dedicated to “Saving Lives with Data,” announced today the launch of the most comprehensive mother-child electronic

April 27, 2024

UnitedHealth skips hearing in the wake of Change cyberattack, triggering call for subpoena

In the first federal hearing focused on the massive cyberattack on Change Healthcare, lawmakers had many important questions for UnitedHealth, which owns Change: Did it

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.